BioTuesdays

Tag - Jonathan Ross Goodman

Knight won’t rest til it bests Paladin

By Len Zehr “It is entirely the goal of Knight Therapeutics (TSX:GUD) to duplicate the success of Paladin Labs,” says president and CEO, Jonathan Ross Goodman, who turned Paladin into a premier distributor of specialty...